The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Nanomedicines-Global Market Insights and Sales Trends 2024
Synopsis
Nanotechnology refers to the engineering of functional systems at the molecular scale. It includes construction of items from the bottom up, using modern techniques and tools to make complete, high-performance products. Nanomedicines refer to medications that are based on the application of nanotechnology in the medical field. They include monitoring, construction, repair, and control of human biological systems at the molecular level, using nanodevices and nanostructures.
The global Nanomedicines market size is expected to reach US$ 246.8 million by 2029, growing at a CAGR of 6.4% from 2023 to 2029. The market is mainly driven by the significant applications of Nanomedicines in various end use industries. The expanding demands from the Hospitals, Clinics and Research Institute,, are propelling Nanomedicines market. Nanoparticles, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Nanoshells segment is estimated at % CAGR for the next seven-year period.
Factors such as aging populations, increasing prevalence of disorders that could be treated better with nanomedicines, and growing awareness about the availability of alternative treatment using nanomedicines are driving the global nanomedicines market.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Nanomedicines, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Nanomedicines market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Nanomedicines market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Nanomedicines sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Nanomedicines covered in this report include Abbott, GE Healthcare, Johnson & Johnson, Merck, Pfizer, CombiMatrix, Celgene, Mallinckrodt and Sigma-Tau Pharmaceuticals, etc.
The global Nanomedicines market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott
GE Healthcare
Johnson & Johnson
Merck
Pfizer
CombiMatrix
Celgene
Mallinckrodt
Sigma-Tau Pharmaceuticals
Teva Pharmaceutical
Nanosphere
UCB SA
Global Nanomedicines market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Nanomedicines market, Segment by Type:
Nanoparticles
Nanoshells
Nanotubes
Nanodevices
Others
Global Nanomedicines market, by Application
Hospitals
Clinics
Research Institute
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Nanomedicines companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Nanotechnology refers to the engineering of functional systems at the molecular scale. It includes construction of items from the bottom up, using modern techniques and tools to make complete, high-performance products. Nanomedicines refer to medications that are based on the application of nanotechnology in the medical field. They include monitoring, construction, repair, and control of human biological systems at the molecular level, using nanodevices and nanostructures.
The global Nanomedicines market size is expected to reach US$ 246.8 million by 2029, growing at a CAGR of 6.4% from 2023 to 2029. The market is mainly driven by the significant applications of Nanomedicines in various end use industries. The expanding demands from the Hospitals, Clinics and Research Institute,, are propelling Nanomedicines market. Nanoparticles, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Nanoshells segment is estimated at % CAGR for the next seven-year period.
Factors such as aging populations, increasing prevalence of disorders that could be treated better with nanomedicines, and growing awareness about the availability of alternative treatment using nanomedicines are driving the global nanomedicines market.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Nanomedicines, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Nanomedicines market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Nanomedicines market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Nanomedicines sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Nanomedicines covered in this report include Abbott, GE Healthcare, Johnson & Johnson, Merck, Pfizer, CombiMatrix, Celgene, Mallinckrodt and Sigma-Tau Pharmaceuticals, etc.
The global Nanomedicines market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott
GE Healthcare
Johnson & Johnson
Merck
Pfizer
CombiMatrix
Celgene
Mallinckrodt
Sigma-Tau Pharmaceuticals
Teva Pharmaceutical
Nanosphere
UCB SA
Global Nanomedicines market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Nanomedicines market, Segment by Type:
Nanoparticles
Nanoshells
Nanotubes
Nanodevices
Others
Global Nanomedicines market, by Application
Hospitals
Clinics
Research Institute
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Nanomedicines companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Nanomedicines
1.1 Nanomedicines Market Overview
1.1.1 Nanomedicines Product Scope
1.1.2 Nanomedicines Market Status and Outlook
1.2 Global Nanomedicines Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Nanomedicines Market Size by Region (2018-2029)
1.4 Global Nanomedicines Historic Market Size by Region (2018-2023)
1.5 Global Nanomedicines Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Nanomedicines Market Size (2018-2029)
1.6.1 North America Nanomedicines Market Size (2018-2029)
1.6.2 Europe Nanomedicines Market Size (2018-2029)
1.6.3 Asia-Pacific Nanomedicines Market Size (2018-2029)
1.6.4 Latin America Nanomedicines Market Size (2018-2029)
1.6.5 Middle East & Africa Nanomedicines Market Size (2018-2029)
2 Nanomedicines Market by Type
2.1 Introduction
2.1.1 Nanoparticles
2.1.2 Nanoshells
2.1.3 Nanotubes
2.1.4 Nanodevices
2.1.5 Others
2.2 Global Nanomedicines Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Nanomedicines Historic Market Size by Type (2018-2023)
2.2.2 Global Nanomedicines Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Nanomedicines Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Nanomedicines Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Nanomedicines Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Nanomedicines Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Nanomedicines Revenue Breakdown by Type (2018-2029)
3 Nanomedicines Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Clinics
3.1.3 Research Institute
3.2 Global Nanomedicines Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Nanomedicines Historic Market Size by Application (2018-2023)
3.2.2 Global Nanomedicines Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Nanomedicines Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Nanomedicines Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Nanomedicines Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Nanomedicines Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Nanomedicines Revenue Breakdown by Application (2018-2029)
4 Nanomedicines Competition Analysis by Players
4.1 Global Nanomedicines Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Nanomedicines as of 2022)
4.3 Date of Key Players Enter into Nanomedicines Market
4.4 Global Top Players Nanomedicines Headquarters and Area Served
4.5 Key Players Nanomedicines Product Solution and Service
4.6 Competitive Status
4.6.1 Nanomedicines Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Abbott
5.1.1 Abbott Profile
5.1.2 Abbott Main Business
5.1.3 Abbott Nanomedicines Products, Services and Solutions
5.1.4 Abbott Nanomedicines Revenue (US$ Million) & (2018-2023)
5.1.5 Abbott Recent Developments
5.2 GE Healthcare
5.2.1 GE Healthcare Profile
5.2.2 GE Healthcare Main Business
5.2.3 GE Healthcare Nanomedicines Products, Services and Solutions
5.2.4 GE Healthcare Nanomedicines Revenue (US$ Million) & (2018-2023)
5.2.5 GE Healthcare Recent Developments
5.3 Johnson & Johnson
5.3.1 Johnson & Johnson Profile
5.3.2 Johnson & Johnson Main Business
5.3.3 Johnson & Johnson Nanomedicines Products, Services and Solutions
5.3.4 Johnson & Johnson Nanomedicines Revenue (US$ Million) & (2018-2023)
5.3.5 Merck Recent Developments
5.4 Merck
5.4.1 Merck Profile
5.4.2 Merck Main Business
5.4.3 Merck Nanomedicines Products, Services and Solutions
5.4.4 Merck Nanomedicines Revenue (US$ Million) & (2018-2023)
5.4.5 Merck Recent Developments
5.5 Pfizer
5.5.1 Pfizer Profile
5.5.2 Pfizer Main Business
5.5.3 Pfizer Nanomedicines Products, Services and Solutions
5.5.4 Pfizer Nanomedicines Revenue (US$ Million) & (2018-2023)
5.5.5 Pfizer Recent Developments
5.6 CombiMatrix
5.6.1 CombiMatrix Profile
5.6.2 CombiMatrix Main Business
5.6.3 CombiMatrix Nanomedicines Products, Services and Solutions
5.6.4 CombiMatrix Nanomedicines Revenue (US$ Million) & (2018-2023)
5.6.5 CombiMatrix Recent Developments
5.7 Celgene
5.7.1 Celgene Profile
5.7.2 Celgene Main Business
5.7.3 Celgene Nanomedicines Products, Services and Solutions
5.7.4 Celgene Nanomedicines Revenue (US$ Million) & (2018-2023)
5.7.5 Celgene Recent Developments
5.8 Mallinckrodt
5.8.1 Mallinckrodt Profile
5.8.2 Mallinckrodt Main Business
5.8.3 Mallinckrodt Nanomedicines Products, Services and Solutions
5.8.4 Mallinckrodt Nanomedicines Revenue (US$ Million) & (2018-2023)
5.8.5 Mallinckrodt Recent Developments
5.9 Sigma-Tau Pharmaceuticals
5.9.1 Sigma-Tau Pharmaceuticals Profile
5.9.2 Sigma-Tau Pharmaceuticals Main Business
5.9.3 Sigma-Tau Pharmaceuticals Nanomedicines Products, Services and Solutions
5.9.4 Sigma-Tau Pharmaceuticals Nanomedicines Revenue (US$ Million) & (2018-2023)
5.9.5 Sigma-Tau Pharmaceuticals Recent Developments
5.10 Teva Pharmaceutical
5.10.1 Teva Pharmaceutical Profile
5.10.2 Teva Pharmaceutical Main Business
5.10.3 Teva Pharmaceutical Nanomedicines Products, Services and Solutions
5.10.4 Teva Pharmaceutical Nanomedicines Revenue (US$ Million) & (2018-2023)
5.10.5 Teva Pharmaceutical Recent Developments
5.11 Nanosphere
5.11.1 Nanosphere Profile
5.11.2 Nanosphere Main Business
5.11.3 Nanosphere Nanomedicines Products, Services and Solutions
5.11.4 Nanosphere Nanomedicines Revenue (US$ Million) & (2018-2023)
5.11.5 Nanosphere Recent Developments
5.12 UCB SA
5.12.1 UCB SA Profile
5.12.2 UCB SA Main Business
5.12.3 UCB SA Nanomedicines Products, Services and Solutions
5.12.4 UCB SA Nanomedicines Revenue (US$ Million) & (2018-2023)
5.12.5 UCB SA Recent Developments
6 North America
6.1 North America Nanomedicines Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Nanomedicines Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Nanomedicines Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Nanomedicines Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Nanomedicines Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Nanomedicines Market Dynamics
11.1 Nanomedicines Industry Trends
11.2 Nanomedicines Market Drivers
11.3 Nanomedicines Market Challenges
11.4 Nanomedicines Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
